| An open label trial of anakinra to prevent respiratory failure in COVID-19 E Kyriazopoulou, P Panagopoulos, S Metallidis, GN Dalekos, G Poulakou, ... Elife 10, e66125, 2021 | 160 | 2021 |
| Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis E Kyriazopoulou, T Huet, G Cavalli, A Gori, M Kyprianou, P Pickkers, ... The Lancet Rheumatology 3 (10), e690-e697, 2021 | 148 | 2021 |
| Smell and taste loss recovery time in COVID-19 patients and disease severity A Printza, M Katotomichelakis, K Valsamidis, S Metallidis, ... Journal of Clinical Medicine 10 (5), 966, 2021 | 73 | 2021 |
| Determinants of intention to get vaccinated against COVID-19 among healthcare personnel in hospitals in Greece HC Maltezou, A Pavli, X Dedoukou, T Georgakopoulou, V Raftopoulos, ... Infection, Disease & Health 26 (3), 189-197, 2021 | 66 | 2021 |
| The clinical course of smell and taste loss in COVID-19 hospitalized patients A Printza, M Katotomichelakis, S Metallidis, P Panagopoulos, A Sarafidou, ... Hippokratia 24 (2), 66, 2020 | 25 | 2020 |
| Calprotectin and imbalances between acute-phase mediators are associated with critical illness in COVID-19 G Kassianidis, A Siampanos, G Poulakou, G Adamis, A Rapti, H Milionis, ... International Journal of Molecular Sciences 23 (9), 4894, 2022 | 19 | 2022 |
| Diabetes mellitus and hypertension as major risk factors of mortality from Covid-19 pneumonia V Petrakis, P Panagopoulos, D Papazoglou, N Papanas Experimental and Clinical Endocrinology & Diabetes 130 (03), 205-206, 2022 | 19 | 2022 |
| Lopinavir/ritonavir as a third agent in the antiviral regimen for SARS-CoV-2 infection P Panagopoulos, V Petrakis, M Panopoulou, G Trypsianis, T Penlioglou, ... Journal of Chemotherapy 33 (3), 193-197, 2021 | 17 | 2021 |
| Early start of oral clarithromycin is associated with better outcome in COVID-19 of moderate severity: the ACHIEVE open-label single-arm trial K Tsiakos, A Tsakiris, G Tsibris, PM Voutsinas, P Panagopoulos, ... Infectious Diseases and Therapy 10 (4), 2333-2351, 2021 | 16 | 2021 |
| Estimation of the determinants for HIV late presentation using the traditional definition and molecular clock‐inferred dates: Evidence that older age, heterosexual risk group … EG Kostaki, S Limnaios, G Adamis, G Xylomenos, M Chini, N Mangafas, ... HIV medicine 23 (11), 1143-1152, 2022 | 13 | 2022 |
| The impact of the COVID-19 pandemic on antimicrobial resistance and management of bloodstream infections V Petrakis, M Panopoulou, P Rafailidis, N Lemonakis, G Lazaridis, I Terzi, ... Pathogens 12 (6), 780, 2023 | 11 | 2023 |
| The antiviral effect of nirmatrelvir/ritonavir during COVID-19 pandemic real-world data V Petrakis, P Rafailidis, G Trypsianis, D Papazoglou, P Panagopoulos Viruses 15 (4), 976, 2023 | 11 | 2023 |
| Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trial K Akinosoglou, A Kotsaki, IM Gounaridi, E Christaki, S Metallidis, ... EClinicalMedicine 56, 2023 | 11 | 2023 |
| Early 3-day course of remdesivir in vaccinated outpatients with SARS-CoV-2 infection. A success story P Panagopoulos, V Petrakis, G Trypsianis, D Papazoglou Journal of Chemotherapy 34 (8), 550-553, 2022 | 11 | 2022 |
| Late presenters of HIV infection in an HIV unit of a tertiary university hospital in a rural region of Greece V Petrakis, P Panagopoulos, T Maltsan, AM Xanthopoulou, I Terzi, ... AIDS Research and Human Retroviruses 36 (7), 601-605, 2020 | 9 | 2020 |
| Anakinra to prevent respiratory failure in COVID-19 E Kyriazopoulou, P Panagopoulos, S Metallidis, GN Dalekos, G Poulakou, ... medRxiv, 2020.10. 28.20217455, 2020 | 8 | 2020 |
| A nationwide study about the dispersal patterns of the predominant HIV-1 subtypes A1 and B in Greece: Inference of the molecular transmission clusters EG Kostaki, M Gova, G Adamis, G Xylomenos, M Chini, N Mangafas, ... Viruses 12 (10), 1183, 2020 | 8 | 2020 |
| Knowledge and perceptions about COVID-19 among health care workers: evidence from COVID-19 hospitals during the second pandemic wave P Ioannou, S Karakonstantis, A Mathioudaki, A Sourris, V Papakosta, ... Tropical Medicine and Infectious Disease 6 (3), 136, 2021 | 6 | 2021 |
| Oral clarithromycin in COVID-19 of moderate severity: the ACHIEVE open-label trial using concurrent matched comparators K Tsiakos, A Tsakiris, G Tsibris, P Voutsinas, P Panagopoulos, ... MedRxiv, 2020.12. 22.20248753, 2020 | 6 | 2020 |
| Greek Remdesivir Cohort (GREC) study: effectiveness of antiviral drug remdesivir in hospitalized patients with COVID-19 pneumonia V Petrakis, V Rapti, K Akinosoglou, C Bonelis, K Athanasiou, ... Microorganisms 10 (10), 1949, 2022 | 5 | 2022 |
